marketcap
Facebook
Twitter
Telegram
Report an ErrorCleveland BioLabs, Inc. Financial Ratios 2011-2024 | CBLI
Annual Financial Ratios Cleveland BioLabs, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-23.7 | -13.4 | -4.9 | -3.7 | -7.0 | -2.1 | 6.5 | -1.8 | -3.2 | -25.3 |
P/S |
216.4 | 32.0 | 15.6 | 18.4 | 5.3 | 9.9 | 2.9 | 3.6 | 16.4 | 11.6 |
EV/EBITDA |
-22.4 | -14.7 | -3.0 | -5.7 | -1.9 | -2.0 | -0.8 | -1.2 | -1.1 | -3.2 |
PEG |
-1.36 | -0.48 | -0.08 | 0.01 | -0.08 | 0.01 | 0.06 | -0.08 | 0.01 | -0.29 |
P/B |
28.3 | 36.2 | 4.9 | 4.8 | 1.4 | 1.8 | 5.9 | 19.4 | 2.9 | 4.6 |
P/CF |
-24.0 | -13.4 | -3.8 | -5.4 | -3.7 | -2.2 | -0.7 | -1.3 | -2.8 | -5.7 |
ROE % |
-119.12 | -268.92 | -99.94 | -131.02 | -20.70 | -84.04 | 91.21 | -1091.91 | -89.01 | -18.04 |
ROA % |
-103.47 | -129.95 | -79.66 | -100.80 | -16.66 | -60.52 | 16.60 | -117.47 | -56.96 | -12.49 |
ROCE % |
-128.47 | -239.85 | -132.50 | -75.52 | -49.47 | -71.76 | -439.00 | -264.95 | -145.98 | -112.86 |
DSO |
16.0 | 124.2 | 80.8 | 103.9 | 36.6 | 85.1 | 26.3 | 19.7 | 4.3 | 72.3 |
DIO |
- | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - |
All numbers in USD currency